Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Sector
Healthcare
Region
US
AUM
4.10M
Fund Score
iShares Health Innovation Active ETF (ARCA:BMED) Quotes, Forecast and News Summary
iShares Health Innovation Active ETF (ARCA: BMED) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $26.68 |
| AUM | 4.10M |
| Dividend | $0.01 |
| Ex-Div Date | Dec 20, 2023 |
| Volume | 79 |
| Market Cap | $64.69B |
| Mgmt Fee | 0.85% |
| P/E Ratio | 29.83 |
| Prev. Close | $26.30 |
| Low | - |
| 52 Wk Low | $23.99 |
| Shares Out | 160.00K |
| Yield | 0.06% |
| Div. Freq | S |
| Avg. Volume Daily | 1.05K |
| Beta | 0.86 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 4.49 |
Recent News
FAQ
Q
How do I buy iShares Health Innovation Active ETF (BMED) stock?
A
You can purchase shares of iShares Health Innovation Active ETF (ARCA:BMED) through any online brokerage.
Q
Who are iShares Health Innovation Active ETF (BMED) competitors?
A
There are no as such competitors for iShares Health Innovation Active ETF.
Q
What is the forecast, or price target, for iShares Health Innovation Active ETF (BMED) stock?
A
There is no analysis for iShares Health Innovation Active ETF to provide a consensus price target.
Q
What is the current price for iShares Health Innovation Active ETF (BMED)?
A
The stock price for iShares Health Innovation Active ETF (ARCA: BMED) is $26.3 last updated January 21, 2025 at 8:00 PM EST.
Q
Does iShares Health Innovation Active ETF (BMED) pay a dividend?
A
There are no upcoming dividends for iShares Health Innovation Active ETF.
Q
When is iShares Health Innovation Active ETF (ARCA:BMED) reporting earnings?
A
iShares Health Innovation Active ETF does not have any upcoming earnings scheduled.
Q
Is iShares Health Innovation Active ETF (BMED) going to split?
A
There is no upcoming split for iShares Health Innovation Active ETF.
| Open | - |
| High | - |
| 52 Wk High | $26.68 |
| AUM | 4.10M |
| Dividend | $0.01 |
| Ex-Div Date | Dec 20, 2023 |
| Volume | 79 |
| Market Cap | $64.69B |
| Mgmt Fee | 0.85% |
| P/E Ratio | 29.83 |
| Prev. Close | $26.30 |
| Low | - |
| 52 Wk Low | $23.99 |
| Shares Out | 160.00K |
| Yield | 0.06% |
| Div. Freq | S |
| Avg. Volume Daily | 1.05K |
| Beta | 0.86 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 4.49 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | All Cap Blend |
| Fund Inception | Sep 29, 2020 |
| Managers | Xiang Liu Jeff Lee Erin Xie |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
To pursue its objective, the Fund will invest at least 80 percent of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. The Fund will consider a company to be principally engaged in the health sciences group of industries if it is classified in an industry within the health sciences group of industries by a third-party industry classification system or it is not classified in any industry by such third-party industry classification system and BFA determines that the company is principally engaged in the health sciences group of industries.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| XTSLA | Blackrock Cash Funds: ... | 6.24% |
| BSX | Boston Scientific Corp... | 3.62% |
| COR | Cencora Inc | 3.48% |
| ISRG | Intuitive Surgical Inc... | 2.82% |
| AS | Argenx Se | 2.68% |
| ALNY | Alnylam Pharmaceutical... | 2.59% |
| MTD | Mettler-Toledo Interna... | 2.52% |
| WST | West Pharmaceutical Se... | 2.48% |
| AMGN | Amgen Inc 2.2 5/19 | 2.43% |
| DHR | Danaher Corp. | 2.04% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved